Intas Pharmaceuticals

Intas Pharmaceuticals

制药业

Ahmedabad，Gujarat 603,660 位关注者

查看职位 关注

关于我们

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

网站
https://intaspharma.com
所属行业
制药业
规模
超过 10,001 人
总部
Ahmedabad，Gujarat
类型
私人持股
领域
Biosimilars Development、Recombinant Proteins Manufacturing、Central Nervous System、Cardio-Diabeto、Plasma Products、Women's Health、Animal Health、Chronic Therapies、Pharmaceuticals、Research and Development、Oncology、Animal Health、Gastroenterology、Urology、Auto immune、rheumatology、nephrology、generic medicine、NDDS products和hormone based therapies

地点

  • 主要

    Sarkhej Gandhinagar Highway

    Near Sola Bridge

    IN，Gujarat，Ahmedabad

    获取路线

Intas Pharmaceuticals员工

查看全部员工

动态

关联主页

相似主页

查看职位

融资

Intas Pharmaceuticals 共 6 轮

上一轮

二级市场
在 Crunchbase 上查看更多信息